The news is directly about Thermo Fisher Scientific and is likely to influence investor sentiment. The lowering of the price target might suggest a potential downside, but the maintained Overweight rating indicates that the analyst still sees the stock as a good investment. The impact on the stock price in the short term is uncertain, hence the neutral score.